![]() |
市場調査レポート
商品コード
1714778
シングルユースバイオプロセシング市場:製品タイプ、ワークフロー段階、用途、最終用途別-2025-2030年世界予測Single-use Bioprocessing Market by Product Type, Workflow Stage, Application, End User - Global Forecast 2025-2030 |
||||||
カスタマイズ可能
適宜更新あり
|
シングルユースバイオプロセシング市場:製品タイプ、ワークフロー段階、用途、最終用途別-2025-2030年世界予測 |
出版日: 2025年04月01日
発行: 360iResearch
ページ情報: 英文 185 Pages
納期: 即日から翌営業日
|
シングルユースバイオプロセシング市場は、2023年に155億6,000万米ドルと評価され、2024年には179億6,000万米ドル、CAGR15.79%で成長し、2030年には434億3,000万米ドルに達すると予測されています。
革新と効率化を通じてバイオプロセスのフロンティアを変革する
主な市場の統計 | |
---|---|
基準年 2023 | 155億6,000万米ドル |
推定年 2024 | 179億6,000万米ドル |
予測年 2030 | 434億3,000万米ドル |
CAGR(%) | 15.79% |
急速に進化するシングルユース・バイオプロセシングの領域では、イノベーションは競争優位性であるだけでなく、市場進化の重要な促進要因でもあります。先端材料、改善された製造方法、洗練された操作プロトコルの融合により、バイオプロセシング・システムは再定義され、ライフサイエンス分野の様々な要求に対してより機敏に対応できるようになっています。新たなテクノロジーとプロセスの最適化は、従来の再利用可能な機器から新しいシングルユースソリューションへのシフトを促進し、バイオ医薬品製造の展望を再構築しています。
この移行は、変動する生産量や急速に変化する規制の枠組みに適応できる、費用対効果に優れ、柔軟でスケーラブルなアプローチへのニーズの高まりに支えられています。製品の完全性の向上、交差汚染リスクの低減、洗浄バリデーションプロセスの合理化などは、シングルユースシステムが提供する主な利点のひとつです。組織がリスクを軽減しながら効率を最大化しようと努める中、最先端のシングルユース技術の統合は、既存のインフラを見直す機会を提供します。
さらに、この分野では研究開発に多額の投資が行われており、これらの技術革新が現在の製造ニーズを満たすだけでなく、将来の課題も予測できるようになっています。全体的な環境は、業界の利害関係者間の強固な対話によって特徴付けられ、その洞察力の結集がプロセスの改善とオペレーションの卓越性を推進しています。このような状況の中で、市場は、品質、安全性、規制遵守への不屈のコミットメントを原動力として、持続的な成長を遂げる態勢を整えています。
市場情勢を再定義する新たな変革の兆し
最近の動向は、シングルユース・バイオプロセシング市場に変革をもたらし、従来の製造パラダイムを根本的に変えています。従来のステンレス製システムからシングルユース装置へと移行する動きは、柔軟性、迅速な展開、初期資本支出の削減が重視されるようになったことが背景にあります。この破壊的なシフトは投資戦略を方向転換させ、主要プレーヤーは現在、既存のインフラストラクチャーにも、デジタル化された新しい環境にもシームレスに統合できるモジュール式ソリューションを採用しています。
同時に市場力学は、個別化医療と少量生産への傾斜の高まりの影響を受けています。特に、フレキシブルな製造ラインの必要性が顕著になり、新たな治療法の市場投入までの時間を短縮する取り組みが推進されています。センサーの強化、自動化の改善、コネクティビティの向上といった技術の進歩は、製造プロセスを合理化しつつあります。そうすることで、製造業者は製造パラメーターをより正確に監視・管理できるようになり、製品の一貫性の向上や規制遵守の強化につながります。
さらに、テクノロジー・イノベーターとバイオ医薬品企業との戦略的パートナーシップや共同事業が、持続的なイノベーションの環境を促進しています。データ分析とリアルタイムモニタリングのプロセス制御への統合は業務効率を再定義し、シングルユースシステムへの新素材の採用はライフサイクルの延長と全体的な経済性の向上をもたらしています。このような状況の中、業界は今日の製造課題を満たすだけでなく、競争の激しい世界市場の将来的な需要も見越した、急速な進化を遂げています。
成長を促進するセグメンテーション洞察の深掘り
シングルユースバイオプロセシング分野を理解する上で重要な要素は、その包括的なセグメンテーションにあります。まず、製品タイプ別にセグメンテーションされた市場を3つの中核分野で検証する:装置・プラント、シンプル・周辺機器、作業機器です。装置・プラントでは、バイオリアクター、クロマトグラフィーシステム、ろ過システム、混合・貯蔵・充填システム、ポンプに焦点が当てられ、バイオリアクター自体は、1000Lまで、1001Lから2000Lまで、2000L以上の容量にわたって精緻な分析が行われます。シンプル&ペリフェラル・エレメントには、バッグ、プローブ&センサー、サンプリング・システム、チューブ、フィルター、コネクター、トランスファー・システムなどの重要なコンポーネントなど、必要不可欠なデバイスが含まれます。特に、プローブ&センサーは、導電率センサー、流量センサー、酸素センサー、pHセンサー、圧力センサー、温度センサーなどの機器に分類されます。作業機器は、細胞培養システムやシリンジなど、操作に不可欠な機器をカバーしています。
ワークフローの段階では、市場はさらに下流工程、充填-仕上げ工程、品質管理・分析、上流工程などの分野に区分され、生産の各段階が最適に分析されるようになっています。アプリケーションは、工程を無菌充填、細胞培養、ろ過、混合、精製、サンプリング、保管に分類することで、戦略的なレイヤーを追加します。最後に、エンドユーザー別のセグメンテーションでは、学術・研究機関、受託製造・研究機関、製薬・バイオテクノロジー企業に焦点を当て、市場の多様な需要の中心を区別しています。これらの詳細なセグメントにより、業務上のニーズを深く理解し、的確な製品開発と展開を確保しながら、新たな成長路線を切り開くための的を絞った戦略を推進することができます。
The Single-use Bioprocessing Market was valued at USD 15.56 billion in 2023 and is projected to grow to USD 17.96 billion in 2024, with a CAGR of 15.79%, reaching USD 43.43 billion by 2030.
Transforming the Bioprocessing Frontier Through Innovation and Efficiency
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 15.56 billion |
Estimated Year [2024] | USD 17.96 billion |
Forecast Year [2030] | USD 43.43 billion |
CAGR (%) | 15.79% |
In the rapidly evolving realm of single-use bioprocessing, innovation is not only a competitive advantage but a critical driver of market evolution. The convergence of advanced materials, improved manufacturing practices, and refined operational protocols has redefined bioprocessing systems, making them more agile and responsive to the varied demands of the life sciences sector. Emerging technologies and process optimizations are catalyzing a shift from traditional, reusable equipment to novel single-use solutions, thereby reshaping the landscape of biopharmaceutical production.
This transition is underpinned by a growing need for cost-effective, flexible, and scalable approaches that can adapt to fluctuating production volumes and rapidly changing regulatory frameworks. Enhanced product integrity, reduced cross-contamination risks, and streamlined cleaning validation processes are among the key benefits offered by single-use systems. As organizations strive to maximize efficiency while mitigating risk, the integration of state-of-the-art single-use technologies provides an opportunity to overhaul existing infrastructure.
Moreover, this sector is witnessing significant investments in research and development, ensuring that these innovations not only meet current manufacturing needs but also anticipate future challenges. The overall environment is characterized by a robust dialogue among industry stakeholders, whose collective insights are driving process improvements and operational excellence. In this context, the market is poised for sustained growth, driven by an unyielding commitment to quality, safety, and regulatory compliance.
Emerging Transformative Shifts Redefining the Market Landscape
Recent trends have sparked a transformation in the single-use bioprocessing market, fundamentally altering traditional manufacturing paradigms. The movement away from conventional stainless-steel systems toward single-use equipment is propelled by an increasing emphasis on flexibility, rapid deployment, and lower upfront capital expenditures. This disruptive shift has reoriented investment strategies, with key players now embracing modular solutions that integrate seamlessly with both existing infrastructures and newer, digitalized environments.
Concurrently, market dynamics are influenced by a growing inclination towards personalized medicine and smaller batch productions. This is particularly significant as the need for flexible manufacturing lines becomes more pronounced, driving initiatives that reduce the time-to-market for emergent therapies. Technological advances-such as enhanced sensors, improved automation, and better connectivity-are streamlining production processes. In doing so, they empower manufacturers to conduct more precise monitoring and control over production parameters, translating into improved product consistency and increased regulatory compliance.
Furthermore, strategic partnerships and collaborative ventures between technology innovators and biopharmaceutical companies are fostering an environment of sustained innovation. The integration of data analytics and real-time monitoring into process control is redefining operational efficiencies, while the adoption of novel materials in single-use systems is extending their lifecycle and overall economic viability. In this climate, the industry is witnessing a fast-paced evolution that not only meets today's manufacturing challenges but also anticipates future demands of a competitive global market.
Deep Dive into Segmentation Insights Catalyzing Growth
A critical component of understanding the single-use bioprocessing sector lies in its comprehensive segmentation. First, the market segmented by product type is examined across three core areas: Apparatus & Plants, Simple & Peripheral Elements, and Work Equipment. Within Apparatus & Plants, the focus extends to bioreactors, chromatography systems, filtration systems, mixing, storage, and filling systems, as well as pumps; bioreactors themselves undergo a refined analysis across capacities ranging from up to 1000L, 1001L to 2000L, and above 2000L. Simple & Peripheral Elements encompass essential devices such as bags, probes & sensors, sampling systems, alongside critical components like tubing, filters, connectors, and transfer systems. In particular, the probes & sensors dimension is further detailed into an array of instruments including conductivity sensors, flow sensors, oxygen sensors, pH sensors, pressure sensors, and temperature sensors. Work Equipment covers devices crucial to operations, such as cell culture systems and syringes.
In terms of the workflow stage, the market segments further into areas such as downstream processing, fill-finish operations, quality control & analytics, and upstream processing, ensuring that each stage of production is optimally analyzed. Applications add another strategic layer by categorizing processes into aseptic filling, cell culture, filtration, mixing, purification, sampling, and storage, which collectively highlight diverse operational complexities and opportunities. Finally, segmentation by end user distinguishes the market's varied demand centers, focusing on academic & research institutes, contract manufacturing and research organizations, as well as pharmaceutical and biotechnology companies. These detailed segments provide an in-depth understanding of operational needs, driving targeted strategies that unlock new growth avenues while ensuring precise product development and deployment.
Based on Product Type, market is studied across Apparatus & Plants, Simple & Peripheral Elements, and Work Equipment. The Apparatus & Plants is further studied across Bioreactors, Chromatography Systems, Filtration System, Mixing, Storage, & Filling Systems, and Pumps. The Bioreactors is further studied across 1001L to 2000L, Above 2000L, and Upto 1000L. The Simple & Peripheral Elements is further studied across Bags, Probes & Sensors, Sampling Systems, and Tubing, Filters, Connectors, & Transfer Systems. The Probes & Sensors is further studied across Conductivity Sensors, Flow Sensors, Oxygen Sensor, pH Sensor, Pressure Sensors, and Temperature Sensors. The Work Equipment is further studied across Cell Culture System and Syringes.
Based on Workflow Stage, market is studied across Downstream Processing, Fill-Finish Operations, Quality Control & Analytics, and Upstream Processing.
Based on Application, market is studied across Aseptic Filling, Cell Culture, Filtration, Mixing, Purification, Sampling, and Storage.
Based on End User, market is studied across Academic & Research Institutes, Contract Manufacturing Organizations & Contract Research Organizations, and Pharmaceutical & Biotechnology Companies.
Key Regional Trends Shaping Bioprocessing Operations
Regional dynamics underscore the diverse growth patterns emerging across global bioprocessing markets. In the Americas, a robust regulatory framework combined with early adoption of cutting-edge technologies creates an environment ripe for innovation, driving investments towards advanced single-use systems. Market leaders in this region have leveraged significant research and development capabilities, integrating new solutions that enhance production efficiency and de-risk the path to commercialization.
Europe, Middle East & Africa collectively carve out a unique position by melding longstanding manufacturing traditions with progressive technological adoption. The region benefits from strong governmental support and strategic industry alliances that bolster infrastructure improvements and streamline regulatory standards. This collaborative ecosystem has enabled companies to deploy highly efficient single-use solutions, translating into operational resilience and enhanced market penetration.
The Asia-Pacific region represents perhaps the most dynamic growth engine, characterized by rapid industrialization, a burgeoning middle class, and escalating demand for both therapeutic and diagnostic innovations. The confluence of technological investment and strategic market reform in this area is propelling the adoption of single-use bioprocessing solutions. As governments in these regions prioritize modernization and innovation, the trajectory for growth is further fueled by rising capital investments, comprehensive training programs, and a surge in international collaborations. Together, these regional insights offer a balanced view of how localized strategies are shaping global industry trends and influencing the deployment of advanced manufacturing technologies.
Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Leading Companies Driving Innovation in Single-use Bioprocessing
Significant market advancements in single-use bioprocessing are driven by a diverse portfolio of industry-leading companies. Organizations such as Agilitech and Aseptic Group have been at the forefront of developing cost-effective solutions that enhance operational efficiency and ensure safety through advanced single-use technologies. By incorporating cutting-edge research and embracing digital transformation, these companies are setting the benchmark for industry standards.
Other innovators including Avantor, Inc. and Bionet Servicios Tecnicos SL provide robust infrastructure and comprehensive process solutions, while firms like BioPharma Dynamics Ltd. and CellBios Healthcare & Lifesciences Pvt. Ltd. focus on refining the nuances of single-use systems to cater to varied production scales. Compagnie de Saint-Gobain and Corning Incorporated are renowned for their contributions to the development of durable and reliable components, positioning them as vital contributors to modern bioprocessing networks. With Cytiva by Danaher Corporation and Entegris, Inc. integrating state-of-the-art monitoring technologies, product quality has noticeably improved, further solidified by the efforts of Eppendorf SE and Foxx Life Sciences.
In addition, established entities such as Freudenberg Group, Getinge AB, and Kuehne + Nagel International AG have extended their expertise to optimize supply chains and streamline production workflows. Market disruptors, including Lonza Group AG Ltd. and Meissner Corporation, are leveraging innovative technologies to drive efficiency. The complementary roles of Merck KGaA, Mettler-Toledo International Inc., and Parker-Hannifin Corporation ensure that every facet of the single-use ecosystem is addressed. With active participation from organizations like PBS Biotech, Inc., PharmNXT Biotech, PSG Dover by Dover Corporation, and Repligen Corporation, the drive towards enhanced bioprocessing is unrelenting. Finishing this ecosystem, companies including SaniSure, Sartorius AG, Satake Multimix Corporation, Single Use Support GmbH, Tekni-Plex, Inc., Thermo Fisher Scientific Inc., and Watson-Marlow Fluid Technology Solutions by Spirax Group PLC further solidify the market's momentum by continuously innovating and refining product offerings. Together, these industry players underscore a relentless commitment to quality, innovation, and operational excellence.
The report delves into recent significant developments in the Single-use Bioprocessing Market, highlighting leading vendors and their innovative profiles. These include Agilitech, Aseptic Group, Avantor, Inc., Bionet Servicios Tecnicos SL, BioPharma Dynamics Ltd., CellBios Healthcare & Lifesciences Pvt. Ltd., Compagnie de Saint-Gobain, Corning Incorporated, Cytiva by Danaher Corporation, Entegris, Inc., Eppendorf SE, Foxx Life Sciences, Freudenberg Group, Getinge AB, Kuehne + Nagel International AG, Lonza Group AG Ltd., Meissner Corporation, Merck KGaA, Mettler-Toledo International Inc., Parker-Hannifin Corporation, PBS Biotech, Inc., PharmNXT Biotech, PSG Dover by Dover Corporation, Repligen Corporation, SaniSure, Sartorius AG, Satake Multimix Corporation, Single Use Support GmbH, Tekni-Plex, Inc., Thermo Fisher Scientific Inc., and Watson-Marlow Fluid Technology Solutions by Spirax Group PLC. Actionable Recommendations That Empower Market Leaders
Industry leaders are encouraged to adopt a forward-thinking approach that balances immediate operational needs with long-term strategic planning. It is essential to invest in R&D initiatives that explore emerging materials and technologies, ensuring that single-use systems remain at the forefront of innovation. Leaders should prioritize partnerships that integrate advanced analytics and real-time monitoring, which are vital for optimizing production flows and ensuring compliance with stringent standards.
Furthermore, diversifying supply chains and establishing resilient logistical networks can mitigate risks associated with market fluctuations. Embracing digital transformation and continuous training programs will enhance both efficiency and employee proficiency across operational stages. Maintaining a robust relationship with regulatory bodies is also recommended to preemptively address compliance challenges and streamline certification processes. By embedding sustainability and cost-effectiveness into core strategies, companies can unlock new avenues for growth, reduce operational downtimes, and ultimately secure a competitive advantage in an increasingly dynamic global market.
Concluding Remarks on Market Potential and Strategic Pathways
The single-use bioprocessing market stands at the crossroads of technological advancement and evolving production needs. As established players and emerging innovators continue to drive the evolution of this market, the confluence of rigorous R&D, strategic partnerships, and adaptive operational strategies will serve as the cornerstone of future success. A renewed focus on quality, efficiency, and sustainability paves the way for significant market advancements, ensuring that bioprocessing solutions not only address current challenges but also anticipate future opportunities.
The dialogue among industry stakeholders remains vibrant, reflecting both the challenges and opportunities presented by the transition to single-use systems. Stakeholders must remain agile, continuously reassessing market trends and aligning strategies with evolving global standards. With this strategic direction, industry leaders are well-equipped to harness the transformative power of these emerging technologies, ultimately driving growth and operational excellence across the bioprocessing landscape.